Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12566371rdf:typepubmed:Citationlld:pubmed
pubmed-article:12566371lifeskim:mentionsumls-concept:C0022658lld:lifeskim
pubmed-article:12566371lifeskim:mentionsumls-concept:C0065374lld:lifeskim
pubmed-article:12566371lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:12566371lifeskim:mentionsumls-concept:C0549634lld:lifeskim
pubmed-article:12566371lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:12566371lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:12566371lifeskim:mentionsumls-concept:C1880371lld:lifeskim
pubmed-article:12566371pubmed:issue4lld:pubmed
pubmed-article:12566371pubmed:dateCreated2003-2-4lld:pubmed
pubmed-article:12566371pubmed:abstractTextDyslipidemia frequently complicates chronic nephropathies and increases the risk of renal and cardiovascular events. This might be ameliorated by drugs, such as angiotensin-converting enzyme inhibitors, which effectively reduce proteinuria.lld:pubmed
pubmed-article:12566371pubmed:languageenglld:pubmed
pubmed-article:12566371pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12566371pubmed:citationSubsetAIMlld:pubmed
pubmed-article:12566371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12566371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12566371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12566371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12566371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12566371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12566371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12566371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12566371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12566371pubmed:statusMEDLINElld:pubmed
pubmed-article:12566371pubmed:monthFeblld:pubmed
pubmed-article:12566371pubmed:issn1524-4539lld:pubmed
pubmed-article:12566371pubmed:authorpubmed-author:JazínE EEElld:pubmed
pubmed-article:12566371pubmed:authorpubmed-author:RemuzziGiusep...lld:pubmed
pubmed-article:12566371pubmed:authorpubmed-author:PernaAnnalisa...lld:pubmed
pubmed-article:12566371pubmed:authorpubmed-author:RuggenentiPie...lld:pubmed
pubmed-article:12566371pubmed:authorpubmed-author:MiseNaobumiNlld:pubmed
pubmed-article:12566371pubmed:authorpubmed-author:PisoniRoberto...lld:pubmed
pubmed-article:12566371pubmed:authorpubmed-author:ArnoldiFederi...lld:pubmed
pubmed-article:12566371pubmed:authorpubmed-author:PezzottaAnnaAlld:pubmed
pubmed-article:12566371pubmed:issnTypeElectroniclld:pubmed
pubmed-article:12566371pubmed:day4lld:pubmed
pubmed-article:12566371pubmed:volume107lld:pubmed
pubmed-article:12566371pubmed:ownerNLMlld:pubmed
pubmed-article:12566371pubmed:authorsCompleteYlld:pubmed
pubmed-article:12566371pubmed:pagination586-92lld:pubmed
pubmed-article:12566371pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:meshHeadingpubmed-meshheading:12566371...lld:pubmed
pubmed-article:12566371pubmed:year2003lld:pubmed
pubmed-article:12566371pubmed:articleTitleDiverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies.lld:pubmed
pubmed-article:12566371pubmed:affiliationClinical Research Center for Rare Diseases Aldo and Cele Daccò, Mario Negri Institute, Bergamo, Italy. manuelap@marionegri.itlld:pubmed
pubmed-article:12566371pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12566371pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12566371pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12566371pubmed:publicationTypeControlled Clinical Triallld:pubmed
pubmed-article:12566371pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed